- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Advocacy
- Careers
- About
- For Pain Patients and Professionals
Papers: 24 Jun 2023 - 30 Jun 2023
RESEARCH TYPE:
Review
Human Studies, Pharmacology/Drug Development
PAIN TYPE:
Abdominal/Pelvic Pain, Inflammation/Inflammatory, Psychological/Comorbidities
2023 Jun 23
Cochrane Database Syst Rev
6
6
Premenstrual syndrome (PMS) is a common problem. Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome. Combined oral contraceptives (COC), which provide both progestin and oestrogen, have been examined for their ability to relieve premenstrual symptoms. A combined oral contraceptive containing drospirenone and a low oestrogen dose has been approved for treating PMDD in women who choose combined oral contraceptives for contraception.